Objectives: Although flexible bronchoscopy with the assistance of miniature radial-probe endobronchial ultrasound (EBUS) is increasingly employed to diagnose peripheral lung cancer, transbronchial biopsies typically offer an insufficient amount of tissue to conduct additional molecular analysis. We evaluated the feasibility of multi-gene analyses from waste brushing samples obtained by EBUS-assisted bronchoscopy. Materials and methods: For lung cancer patients with positive brushing cytology, analysis of EGFR, K-ras and EML4-ALK fusions were carried out, utilizing reverse transcription-polymerase chain reaction and Sanger sequencing on the cell-derived RNA retrieved from waste brushing samples. Results: EBUS-guided brushings were judged p...
Introduction: Molecular profiling of advanced non-small cell lung cancer (NSCLC) has become essentia...
Introduction:Molecular testing for epidermal growth factor receptor (EGFR) and KRAS mutations is of ...
Introduction:Pleural effusion is frequently observed in patients with advanced lung cancer. Although...
Introduction Mini-invasive bronchoscopic techniques (such as radial endobronchial ultrasonography (r...
Introduction:Although genetic information is essential for molecular targeted therapy for personaliz...
Background: Biomarker-driven clinical trials in advanced non-small cell lung cancer (NSCLC) usually ...
BackgroundRadial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose p...
Introduction:Patients with stage IV non-small-cell lung cancer harboring an activating epidermal gro...
Increased early detection and personalized therapy for lung cancer have coincided with greater use o...
IntroductionAdequate tumor acquisition is essential to identify somatic molecular alterations in non...
PURPOSE: Knowledge of tumor mutational status has become a priority for effective NSCLC-tailored tre...
Contains fulltext : 89465.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
© 2018 Dr. Tracy Li-Tsein LeongThe last decade has seen a paradigm shift in the clinical approach to...
Introduction:Patients with stage IV non–small-cell lung cancer harboring an activating epidermal gro...
BackgroundRadial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose p...
Introduction: Molecular profiling of advanced non-small cell lung cancer (NSCLC) has become essentia...
Introduction:Molecular testing for epidermal growth factor receptor (EGFR) and KRAS mutations is of ...
Introduction:Pleural effusion is frequently observed in patients with advanced lung cancer. Although...
Introduction Mini-invasive bronchoscopic techniques (such as radial endobronchial ultrasonography (r...
Introduction:Although genetic information is essential for molecular targeted therapy for personaliz...
Background: Biomarker-driven clinical trials in advanced non-small cell lung cancer (NSCLC) usually ...
BackgroundRadial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose p...
Introduction:Patients with stage IV non-small-cell lung cancer harboring an activating epidermal gro...
Increased early detection and personalized therapy for lung cancer have coincided with greater use o...
IntroductionAdequate tumor acquisition is essential to identify somatic molecular alterations in non...
PURPOSE: Knowledge of tumor mutational status has become a priority for effective NSCLC-tailored tre...
Contains fulltext : 89465.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
© 2018 Dr. Tracy Li-Tsein LeongThe last decade has seen a paradigm shift in the clinical approach to...
Introduction:Patients with stage IV non–small-cell lung cancer harboring an activating epidermal gro...
BackgroundRadial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose p...
Introduction: Molecular profiling of advanced non-small cell lung cancer (NSCLC) has become essentia...
Introduction:Molecular testing for epidermal growth factor receptor (EGFR) and KRAS mutations is of ...
Introduction:Pleural effusion is frequently observed in patients with advanced lung cancer. Although...